Posted inMarket
Pulmovant Set to Reveal Phase 2 Mosliciguat Study Findings on Tuesday
Pulmovant is preparing to unveil key Phase 2 clinical trial data for mosliciguat on Tuesday, offering new insights for respiratory medicine.
Posted inMarket
Vaxcyte Stock Rises Following Leadership Updates and VAX-31 Timeline
Vaxcyte shares climbed following the appointment of new executives and the announcement of an upcoming timeline for VAX-31 clinical data.
